Determination of a distinguished interferon gamma epitope recognized by monoclonal antibody relating to autoantibody associated immunodeficiency.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
09 05 2022
09 05 2022
Historique:
received:
28
12
2021
accepted:
27
04
2022
entrez:
9
5
2022
pubmed:
10
5
2022
medline:
12
5
2022
Statut:
epublish
Résumé
Anti-interferon gamma autoantibodies (anti-IFN-γ autoAbs) neutralize the IFN-γ-mediated functions, contributing to immunodeficiency. A particular autoAb in patient serum had been previously demonstrated to recognize the same determinant on IFN-γ as the neutralizing anti-IFN-γ monoclonal antibody clone B27 (B27 mAb). This study explored the epitope recognized by B27 mAb. The specific peptide sequence recognized by B27 mAb, TDFLRMMLQEER, was retrieved from a phage display random peptide library. Sequence alignment and homology modeling demonstrated that the queried phage peptide sequence and structure were similar to amino acids at position 27-40 (TLFLGILKNWKEES) of the human IFN-γ. This determinant resides in the contact surface of IFN-γ and interferon gamma receptor 1. To elucidate the crucial amino acids, mutations were introduced by substituting T27 and T27F29L30 with alanine or deleting the amino acid residues T27-L33. The binding of B27 mAb to IFN-γ T27A using western blotting was lesser than that to wild-type. The interaction with triple mutant and T27-L33 deletion mutant using western blotting and sandwich ELISA was abolished. The finding demonstrated that T27, F29, and L30 are critical residues in the B27 antigenic determinant. Identification of the functional domain of IFN-γ decrypted the relevance of neutralizing autoAb in adult-onset immunodeficiency.
Identifiants
pubmed: 35534543
doi: 10.1038/s41598-022-11774-9
pii: 10.1038/s41598-022-11774-9
pmc: PMC9085737
doi:
Substances chimiques
Amino Acids
0
Antibodies, Monoclonal
0
Autoantibodies
0
Epitopes
0
Interferon-gamma
82115-62-6
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
7608Informations de copyright
© 2022. The Author(s).
Références
J Interferon Cytokine Res. 2016 Sep;36(9):542-51
pubmed: 27336613
N Engl J Med. 2012 Aug 23;367(8):725-34
pubmed: 22913682
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
PLoS One. 2013 Sep 27;8(9):e76371
pubmed: 24086734
Appl Biochem Biotechnol. 2013 Oct;171(3):583-9
pubmed: 23807489
J Biol Chem. 1994 Jun 10;269(23):16159-62
pubmed: 8206916
J Immunol. 2005 Oct 1;175(7):4769-76
pubmed: 16177125
Infection. 2011 Feb;39(1):65-71
pubmed: 21128092
Cytokine Growth Factor Rev. 2009 Apr;20(2):97-113
pubmed: 19268625
J Biol Chem. 1998 May 1;273(18):10919-25
pubmed: 9556569
Proc Natl Acad Sci U S A. 2013 May 7;110(19):7832-7
pubmed: 23620516
Exp Biol Med (Maywood). 2018 Apr;243(7):621-626
pubmed: 29512397
J Immunol Res. 2019 May 30;2019:1629258
pubmed: 31275997
Clin Exp Immunol. 1994 Dec;98(3):520-5
pubmed: 7994916
Annu Rev Immunol. 2014;32:635-57
pubmed: 24499273
Structure. 2000 Sep 15;8(9):927-36
pubmed: 10986460
Intern Med. 2018 Oct 15;57(20):3041-3045
pubmed: 29780147
Cytokine. 2010 Apr;50(1):1-14
pubmed: 20036577
Bio Protoc. 2017 Feb 05;7(3):e2124
pubmed: 34458447
Nature. 2019 Mar;567(7746):56-60
pubmed: 30814731
Front Immunol. 2019 Aug 14;10:1905
pubmed: 31474987
Nat Med. 2016 Sep;22(9):994-1001
pubmed: 27525523
Nat Rev Immunol. 2018 Sep;18(9):545-558
pubmed: 29921905
Methods. 2001 Jul;24(3):240-6
pubmed: 11403573